01 11VERTEX PHARMS INC
01 1110022352
01 11Blank
01 11Y
01 112027-04-09
Patent Expiration Date : 2027-04-09
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 10022352
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210491
Patent Use Code : U-2343
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US Patent Number : 10022352
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 218730
Patent Use Code : U-4081
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10022352
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-3596
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 10022352
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210491
Patent Use Code : U-2573
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 10022352
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210491
Patent Use Code : U-2573
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 10022352
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210491
Patent Use Code : U-2343
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US Patent Number : 10022352
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 218730
Patent Use Code : U-4081
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10022352
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-3156
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10022352
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-3156
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10022352
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-3596
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
